Rise Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-46
Closed -$13.2K – 843
2025
Q3
$13.2K Buy
46
+2
+5% +$536 ﹤0.01% 839
2025
Q2
$11.6K Hold
44
– – ﹤0.01% 896
2025
Q1
$10.2K Buy
+44
New +$10.7K ﹤0.01% 952
2023
Q2
– Sell
-5
Closed -$918 – 740
2023
Q1
$918 Buy
+5
New +$1.03K ﹤0.01% 668

Other funds holding LH

Rise Advisors's LH Position: Q4 2025 in Review

Rise Advisors sold out of Labcorp (LH) in Q4 2025, closing a stake of 46 shares — an estimated $13.2K sold.

Rise Advisors first reported a position in LH in Q1 2023 and held it in 4 quarters. The position peaked at $13.2K in Q3 2025. 1,029 funds tracked by Wall St. Rank hold LH as of Q4 2025.

  • Rise Advisors reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 46 Labcorp shares in Q4 2025, an estimated $13.2K.
  • Rise Advisors first reported a position in Labcorp in Q1 2023 and held it in 4 quarters.
  • Rise Advisors's Labcorp position peaked at $13.2K in Q3 2025.
  • 1,029 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.